Two South Carolina eye care practices have joined Carolina Eyecare Physicians, a U.S. Eye member.

Eye Consultants of Atlanta/Piedmont System Ambulatory Surgery Center suffered a data breach after hard copies of medical records were improperly discarded.

Wilmington (N.C.) Eye named Kathy Erickson the practice's first CEO, according to a Wilmington Biz report. 

Eye Surgery Center of Hawaii in Dole Cannery expanded its space, Pacific Business News reported June 30.

OcuTerra named a CMO, and Visus Therapeutics named six executives. 

Physician-led ophthalmology management company US Eye partnered with three practices in South Carolina and Florida, according to a June 29 release. 

Clinical stage ophthalmology pharmaceutical company OcuTerra introduced David Tanzer, MD, as its newest chief medical officer and executive vice president of clinical and medical affairs, according to a June 25 press release.

EyesNY (Saratoga Springs) opened its seventh location in Clifton Park, N.Y., according to a June 25 announcement.

Eighty-nine percent of ophthalmologists are board certified, according to Merritt Hawkins physician revenue calculator and Medscape's 2021 "Physician Compensation Report."

A survey from the American Academy of Ophthalmologists shows that more than 96 percent of ophthalmologists nationwide are vaccinated.

Three percent of ophthalmologists have a net worth of at least $5 million, according to Medscape.

Troy, Mich.-based TruVista Surgery Center joined Sunvera Group, a private equity-backed management services organization, according to a June 16 news release.

Ophthalmic pharmaceutical company Visus Therapeutics introduced six new executives it has appointed to lead the company.

Eye care group EyeSouth Partners introduced Kenneth Zongor as its next CFO, succeeding Jason Shafer, who will continue with the company as chief development officer, according to a June 15 press release.

Columbia University in New York City recently introduced Steven E. Rosenberg, MD, as director of pediatric ophthalmology and the Anne S. Cohen Endowed Professor of Pediatric Ophthalmology.

Ophthalmic pharmaceutical company Alimera recently added David Dyer, MD, as its chief retina specialist.

Grand Rapids, Mich.-based Vitreo-Retinal Associates signed a 10-year lease on a space in Kalamazoo, RE Journals reported June 8.

Sarasota, Fla.-based US Eye practices are the first to use Johnson & Johnson Vision's TECNIS Synerg Intraocular Lens for cataract surgery, the practice announced in a June 7 news release.

U.S. biotech company Pieris Pharmaceuticals partnered with Roche subsidiary Genentech for $20 million up front and may be eligible to receive more than $1.4 billion in additional milestone payments, The Pharma Letter reported May 25.

Two ophthalmology clinics are opening in North Carolina, and private equity-backed ophthalmology companies are expanding.